Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax
The DOI matches its Crossref record.
Abstract
In Papua, Indonesia, the antimalarial susceptibility of Plasmodium vivax ( n = 216) and P. falciparum ( n = 277) was assessed using a modified schizont maturation assay for chloroquine, amodiaquine, artesunate, lumefantrine, mefloquine, and piperaquine. The most effective antimalarial against P. vivax and P. falciparum was artesunate, with geometric mean 50% inhibitory concentrations (IC 50 s) (95% confidence intervals [CI]) of 1.31 nM (1.07 to 1.59) and 0.64 nM (0.53 to 0.79), respectively. In contrast, the geometric mean chloroquine IC 50 for P. vivax was 295 nM (227 to 384) compared to only 47.4 nM (42.2 to 53.3) for P. falciparum . Two factors were found to significantly influence the in vitro drug response of P. vivax : the initial stage of the parasite and the duration of the assay. Isolates of P. vivax initially at the trophozoite stage had significantly higher chloroquine IC 50 s (478 nM [95% CI, 316 to 722]) than those initially at the ring stage (84.7 nM [95% CI, 45.7 to 157]; P < 0.001). Synchronous isolates of P. vivax and P. falciparum which reached the target of 40% schizonts in the control wells within 30 h had significantly higher geometric mean chloroquine IC 50 s (435 nM [95% CI, 169 to 1,118] and 55.9 nM [95% CI, 48 to 64.9], respectively) than isolates that took more than 30 h (39.9 nM [14.6 to 110.4] and 36.9 nM [31.2 to 43.7]; P < 0.005). The results demonstrate the marked stage-specific activity of chloroquine with P. vivax and suggest that susceptibility to chloroquine may be associated with variable growth rates. These findings have important implications for the phenotypic and downstream genetic characterization of P. vivax .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, it is complicated to assess P. vivax in vitro susceptibility because (1) longterm cultures of P. vivax isolates are not routinely feasible and (2) ex vivo drug susceptibility assays are difficult to implement and are difficult to interpret because P. vivax infections are typically asynchronous and the parasite's susceptibility depends on its stage [13,14].”
From Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy for Plasmodium vivax Malaria (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 25
- 10.4269/ajtmh.1991.44.547 · DOI · Paper page
- 10.4269/ajtmh.1997.56.621 · DOI · Paper page
- 10.1086/512242 · DOI · Paper page
- 10.4269/ajtmh.2004.70.395 · DOI
- 10.1128/AAC.01385-06 · doi:10.1128/aac.01385-06
- Fryauff, D. J., S. Tuti, A. Mardi, S. Masbar, R. Patipelohi, B. Leksana, K. C. Kain, M. J. Bangs, T. L. Richie, and J. K. Baird. 1998. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am. J. Trop. Med. Hyg.59:513-518. · doi:10.4269/ajtmh.1998.59.513
- 10.1016/0035-9203(84)90145-7 · doi:10.1016/0035-9203(84)90145-7
- 10.1016/0092-8674(92)90642-P · DOI · Paper page
- Hamedi, Y., M. Nateghpour, B. Soonthornsata, P. Tan-ariya, S. Kojima, D. Chindanond, and S. Looareesuwan. 2003. Monitoring of Plasmodium vivax sensitivity to chloroquine in vitro in Thailand. Trans. R. Soc. Trop. Med. Hyg.97:435-437. · doi:10.1016/s0035-9203(03)90080-0
- 10.1086/512241 · DOI · Paper page
- 10.1016/j.exppara.2006.02.006 · doi:10.1016/j.exppara.2006.02.006
- Lux, D., S. Prajakwong, H. Kollaritsch, G. Wernsdorfer, and W. H. Wernsdorfer. 2003. In-vitro sensitivity testing of Plasmodium vivax: response to lumefantrine and chloroquine in northwestern Thailand. Wien. Klin. Wochenschr.115(Suppl. 3):50-54.
- 10.4269/ajtmh.1974.23.1007 · doi:10.4269/ajtmh.1974.23.1007
- 10.1128/AAC.44.6.1680-1685.2000 · DOI · Paper page
- 10.1016/S0140-6736(07)60160-3 · DOI · Paper page
- 10.1016/j.trstmh.2006.06.008 · DOI · Paper page
- 10.1016/j.ijpara.2007.05.003 · DOI
- 10.1016/S0140-6736(89)91792-3 · DOI · Paper page
- 10.1128/AAC.47.1.170-173.2003 · DOI
- 10.4269/ajtmh.2001.65.90 · doi:10.4269/ajtmh.2001.65.90
- 10.4269/ajtmh.2003.68.416 · DOI
- 10.1371/journal.pone.0001089 · DOI · Paper page
- 10.1016/S0001-706X(02)00056-6 · doi:10.1016/s0001-706x(02)00056-6
- 10.1016/j.trstmh.2005.04.024 · DOI
- 10.1111/j.1550-7408.1983.tb05336.x · doi:10.1111/j.1550-7408.1983.tb05336.x
Cited by
Comparative genomics of the neglected human malaria parasite Plasmodium vivax
Carlton, J. M., Adams, J. H., Silva, J. C., Bidwell, S. L., Lorenzi, H., Caler, E., Crabtree, J., Angiuoli, S. V., Merino, E. F., Amedeo, P., et al. (2008) · Nature · doi:10.1038/nature07327 · Cited by 835
Self-citationTjitra, E., Anstey, N. M., Sugiarto, P., Warikar, N., Kenangalem, E., Karyana, M., Lampah, D. A., & Price, R. N. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050128 · Cited by 611
Self-citationA novel multiple-stage antimalarial agent that inhibits protein synthesis
Baragaña, B., Hallyburton, I., Lee, M. C. S., Norcross, N. R., Grimaldi, R., Otto, T. D., Proto, W. R., Blagborough, A. M., Meister, S., Wirjanata, G., et al. (2015) · Nature · doi:10.1038/nature14451 · Cited by 454
Self-citationTargeting Plasmodium PI(4)K to eliminate malaria
McNamara, C. W., Lee, M. C. S., Lim, C. S., Lim, S. H., Roland, J., Nagle, A., Simon, O., Yeung, B. K. S., Chatterjee, A. K., McCormack, S. L., et al. (2013) · Nature · doi:10.1038/nature12782 · Cited by 431
Self-citationThe pathophysiology of vivax malaria
Anstey, N. M., Russell, B., Yeo, T. W., & Price, R. N. (2009) · Trends in Parasitology · doi:10.1016/j.pt.2009.02.003 · Cited by 428
Self-citationGlobal extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Price, R. N., von Seidlein, L., Valecha, N., Nosten, F., Baird, J. K., & White, N. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70855-2 · Cited by 388
Self-citationNew developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
Price, R. N., Douglas, N. M., & Anstey, N. M. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832f14c1 · Cited by 343
Self-citationQuinolone-3-Diarylethers: A New Class of Antimalarial Drug
Nilsen, A., LaCrue, A. N., White, K. L., Forquer, I. P., Cross, R. M., Marfurt, J., Mather, M. W., Delves, M. J., Shackleford, D. M., Saenz, F. E., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005029 · Cited by 292
Self-citationDrug‐resistant malaria: Molecular mechanisms and implications for public health
Petersen, I., Eastman, R., & Lanzer, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.042 · Cited by 289
Resistance to Therapies for Infection by Plasmodium vivax
Baird, J. K. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-09 · Cited by 262
Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand
Rijken, M. J., Boel, M. E., Russell, B., Imwong, M., Leimanis, M. L., Phyo, A. P., Muehlenbachs, A., Lindegardh, N., McGready, R., Rénia, L., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-113 · Cited by 62
“Blood samples were also collected on these days for ex vivo sensitivity assays but only one (D31) harboured parasites at a developmental stage suitable for meaningful analysis [12].”
BackgroundSelf-citationPopovici, J., Pierce-Friedrich, L., Kim, S., Bin, S., Run, V., Lek, D., Hee, K. H. D., Lee Soon-U, L., Cannon, M. V., Serre, D., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy484 · Cited by 59
Metadata
- Authors
- Russell, B., Chalfein, F., Prasetyorini, B., Kenangalem, E., Piera, K., Suwanarusk, R., Brockman, A., Prayoga, P., Sugiarto, P., Cheng, Q., Tjitra, E., Anstey, N. M., & Price, R. N.
- Affiliations
- International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia
- Menzies School of Health Research—National Institute of Health Research and Development Malaria Research Program, Timika, Indonesia
- National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
- Mitra Masyarakat Hospital, Timika, Indonesia
- Department of Drug Resistance and Diagnostics, Australian Army Malaria Institute, Brisbane, Australia
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-03
- Volume
- 52
- Issue
- 3
- Pages
- 1040-1045
- ISSN
- 0066-4804
- 1098-6596
- Cited by
- 118
- References
- 0
- Language
- en
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.